PBE Holdings List

As of Dec 3, 2025

No.	Symbol	Name	% Weight	Shares
1	ALNY	Alnylam Pharmaceuticals, Inc.	5.39%	29,494
2	AMGN	Amgen Inc.	5.11%	38,293
3	BIIB	Biogen Inc.	5.06%	72,430
4	ILMN	Illumina, Inc.	5.02%	101,676
5	UTHR	United Therapeutics Corporation	4.98%	26,838
6	GILD	Gilead Sciences, Inc.	4.93%	102,236
7	INCY	Incyte Corporation	4.72%	120,549
8	REGN	Regeneron Pharmaceuticals, Inc.	4.70%	16,819
9	BCRX	BioCryst Pharmaceuticals, Inc.	3.10%	1,022,796
10	MNKD	MannKind Corporation	2.94%	1,361,734
11	ACAD	ACADIA Pharmaceuticals Inc.	2.92%	292,289
12	NBIX	Neurocrine Biosciences, Inc.	2.90%	49,456
13	COLL	Collegium Pharmaceutical, Inc.	2.83%	153,076
14	IONS	Ionis Pharmaceuticals, Inc.	2.81%	88,967
15	EXEL	Exelixis, Inc.	2.81%	165,342
16	VCYT	Veracyte, Inc.	2.76%	149,587
17	TECH	Bio-Techne Corporation	2.71%	110,028
18	RPRX	Royalty Pharma plc	2.69%	175,741
19	RGEN	Repligen Corporation	2.69%	41,766
20	QGEN	Qiagen N.V.	2.67%	147,939
21	FOLD	Amicus Therapeutics, Inc.	2.67%	706,339
22	TGTX	TG Therapeutics, Inc.	2.66%	218,099
23	MDGL	Madrigal Pharmaceuticals, Inc.	2.66%	11,882
24	CPRX	Catalyst Pharmaceuticals, Inc.	2.65%	296,898
25	PTGX	Protagonist Therapeutics, Inc.	2.65%	79,664

As of Dec 3, 2025